Ann: Market Update - Hydrix Acquisition, page-18

That's the trouble with this company, no one has any idea whether recalibration is still taking place,
or the trials are back under way.
They could of easily given us a simple update as to where they are at with this device.
Personally, I don't think it's back in the field yet. The last thing they need prior to the AGM
is too upset shareholders once again.
I am voting against the 10mil performance options as It does not state just what are the
performance hurdles that are too be meet 18/19.
I want too know just what PSY have in mind as to what they classify as performance hurdles
good luck too all